Aravive Inc. (ARAV) Prices 3.33M Share Common Offering at $7.50/Sh
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/18/2026
- Wall Street indexes slip as oil prices rise, retail results awaited
- Trump threatens to bomb Oman over Iran stance
- Why this Wall Street strategist says the "trade is long gold"
- U.S. EV market shows signs of bottoming out: Bernstein
- Micron rises as White House presses Apple to avoid Chinese memory chips
- Wall Street indexes slip as oil prices rise, retail results awaited
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
- Micron rises as White House presses Apple to avoid Chinese memory chips
- Trump threatens to bomb Oman over Iran stance
- H.C. Wainwright Reiterates Buy Rating on Soluna (SLNH)
After-Hours Movers 11/26: (ONTX) (TNXP) (BOX) Higher; (ARAV) (ATHX) (GES) Lower (more...)
November 26, 2019 6:00 PM ESTAfter-Hours Movers
Onconova Therapeutic (NASDAQ: ONTX) 13.4% HIGHER; Steven Cohen's fund Point72 Asset Management, L.P. disclosed a 9.99%, or 3,230,434 share, stake in the company.
Aravive, Inc. (Nasdaq: ARAV) 13.3% LOWER; announced that it has commenced an underwritten public offering of the sale of its shares of common stock.
Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) 13.3% HIGHER; received the official minutes from the Breakthrough Therapy Type B Clinical... More
Aravive Inc. (ARAV) Plans Public Offering of Common Stock
November 26, 2019 5:14 PM ESTAravive, Inc. (Nasdaq: ARAV), a clinical-stage biopharmaceutical company developing treatments designed to halt the progression of life-threatening diseases, including cancer and fibrosis, today announced that it has commenced an underwritten public offering of the sale of its shares of common stock. In connection with... More
